Abstract
e16051Background: Approximately 50-60% of nonseminomatous germ-cell tumors (NSGCT) present with clinical stage I (CS I). Initial active surveillance, adjuvant chemotherapy and retroperitoneal lymph...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have